NCT05991297Completed
Effects of Deep Sensory Assisted Rehabilitation on Gait and Balance in Patients With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 13 Jan 2026
Brief summary (registry, in English)
The effect of physical therapy and rehabilitation on improving the gait and balance disorders of patients has been proven. FTR applications in MS patients have become routine in developed countries. However, due to the high patient density in our country, FTR cannot be performed at the rate we want due to different reasons such as the inability to separate areas special for MS patients, the lack of special FTR applications for MS patients, and the inability to perform regular FTR follow-ups. Even if FTR is recommended and performed, our patients think that FTR is not very effective due to the above reasons and they do not continue. A team of neurology, physical therapy specialists, and physiotherapists was formed, in-service training was completed and a special rehabilitation program for MS patients was created. First of all, we will apply routine classical FTR to our patients. Sensory and deep sensory disorders, which are more common and severe, especially in the lower extremities, also negatively affect gait and balance. A rehabilitation program was created by adding exercises to improve sensation and deep sense, along with muscle strengthening. The results of the 1st and 21st sessions of the patients in the two groups who underwent classical rehabilitation and deep sensory-assisted rehabilitation will be compared. It was planned to evaluate the gait and balance parameters of the patients as numerical data with clinical scales and the C mill device we used in walking and balance exercises.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 26 Jul 2023
- Start date
- 1 Jun 2023
- Primary completion date
- 1 Feb 2024
- Lead sponsor
- Nermin Çalışır
- Diseases
- Multiple sclerosis
- NCT number
- NCT05991297
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 1 Jun 2023 to the primary completion date, 1 Feb 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- schizoaffective disorder
- diabetes mellitus
- cognitive impairment (at a level that may interfere with communication)
Other
- lower extremity amputation
- shortness on one side creating asymmetry in the lower extremities
Who the study is looking for
- Diagnosed with multiple sclerosis
- 20-60 years old
- EDSS between 3.0-5.5 Those with EDSS 0-2.5 and spinal and/or cerebellar involvement
- Had the last MS attack at least 3 months ago
Age in the registry: 20 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Romatem Physical Therapy and Rehabilitation Hospitals Bursa Hospital Coordinator of this site? Confirm its status | Bursa | Turkey (Türkiye) | Unknown status |
| University of Health Sciences Bursa Yuksek Ihtisas Training and Research Hospital Coordinator of this site? Confirm its status | Bursa | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.